A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression
- PMID: 17188503
- DOI: 10.1016/j.nbd.2006.11.006
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression
Abstract
Unverricht-Lundborg disease (EPM1), the most common progressive myoclonic epilepsy, is associated with a defect of cystatin B (CSTB), a protease inhibitor. We used CSTB knockout mice to test the hypothesis that EPM1 onset is related to a latent hyperexcitability and that progression depends on higher susceptibility to seizure-induced cell damage. Hippocampal slices prepared from CSTB-deficient mice were hyperexcitable, as they responded to afferent stimuli in CA1 with multiple population spikes and kainate perfusion provoked the appearance of epileptic-like activity earlier than in WT mice. This hyperexcitability may depend on loss of inhibition, because the density of GABA-immunoreactive cells was reduced in the hippocampus of CSTB knockouts. In vivo, CSTB-deficient mice treated with kainate displayed increased susceptibility to seizures, with shorter latency to seizure onset and increased seizure severity compared with WT littermates. Furthermore, a greater degree of neuronal damage was observed in CSTB-deficient than in WT mice after seizures of identical grade, indicating increased susceptibility to seizure-induced cell death.
Similar articles
-
Molecular background of EPM1-Unverricht-Lundborg disease.Epilepsia. 2008 Apr;49(4):557-63. doi: 10.1111/j.1528-1167.2007.01422.x. Epub 2007 Nov 19. Epilepsia. 2008. PMID: 18028412 Review.
-
Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy.Epilepsia. 2006 Oct;47(10):1650-4. doi: 10.1111/j.1528-1167.2006.00638.x. Epilepsia. 2006. PMID: 17054687
-
Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.Eur J Hum Genet. 2007 Feb;15(2):185-93. doi: 10.1038/sj.ejhg.5201723. Epub 2006 Sep 27. Eur J Hum Genet. 2007. PMID: 17003839
-
Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.Nat Genet. 1998 Nov;20(3):251-8. doi: 10.1038/3059. Nat Genet. 1998. PMID: 9806543
-
Clinical picture of EPM1-Unverricht-Lundborg disease.Epilepsia. 2008 Apr;49(4):549-56. doi: 10.1111/j.1528-1167.2008.01546.x. Epub 2008 Mar 5. Epilepsia. 2008. PMID: 18325013 Review.
Cited by
-
Characterization of PTZ-induced seizure susceptibility in a down syndrome mouse model that overexpresses CSTB.PLoS One. 2011;6(11):e27845. doi: 10.1371/journal.pone.0027845. Epub 2011 Nov 30. PLoS One. 2011. PMID: 22140471 Free PMC article.
-
Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis.Malar J. 2009 Aug 5;8:188. doi: 10.1186/1475-2875-8-188. Malar J. 2009. PMID: 19656408 Free PMC article.
-
Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs.Cells. 2022 Nov 4;11(21):3491. doi: 10.3390/cells11213491. Cells. 2022. PMID: 36359887 Free PMC article.
-
Role of cystatin C in neuroprotection and its therapeutic implications.Am J Pathol. 2010 Nov;177(5):2163-5. doi: 10.2353/ajpath.2010.100829. Epub 2010 Sep 23. Am J Pathol. 2010. PMID: 20864683 Free PMC article.
-
Age-Dependent Reduction in the Expression Levels of Genes Involved in Progressive Myoclonus Epilepsy Correlates with Increased Neuroinflammation and Seizure Susceptibility in Mouse Models.Mol Neurobiol. 2022 Sep;59(9):5532-5548. doi: 10.1007/s12035-022-02928-x. Epub 2022 Jun 22. Mol Neurobiol. 2022. PMID: 35732865
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous